Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release

International Journal of Pharmaceutics

Volumn 436, Issue 1-2, 2012, Pages 58-65

  Milović, Mladen ^a   Djuriš, Jelena ^a   Djekić, Ljiljana ^a   Vasiljević, Dragana ^a   Ibrić, Svetlana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Carbamazepine; Dissolution rate improvement; Magnesium aluminometasilicate; Porous silica; Solid self microemulsifying drug delivery systems

Indexed keywords

ADSORBENT; ATTAPULGITE; CAPRIC TRIGLYCERIDE; CARBAMAZEPINE; COSURFACTANT; CREMOPHOR; DRUG CARRIER; MAGNESIUM ALUMINOMETASILICATE; POLYSORBATE 80; SURFACTANT; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; DILUTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STRUCTURE; MICROEMULSION; PHOTON CORRELATION SPECTROSCOPY; PRIORITY JOURNAL; SOLID SELF MICROEMULSIFYING DRUG DELIVERY SYSTEM; WATER CONTENT;

ALUMINUM SILICATES; ANTICONVULSANTS; CARBAMAZEPINE; DRUG CARRIERS; EMULSIONS; MAGNESIUM; POLYETHYLENE GLYCOLS; POLYSORBATES; POROSITY; SILICON DIOXIDE; SOLUBILITY; SURFACE-ACTIVE AGENTS; TRIGLYCERIDES;

EID: 84865284761     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.06.032     Document Type: Article

References (46)

1. V. Agarwal, A. Siddiqui, H. Ali, and S. Nazzal Dissolution and powder flow characterization of solid self-emulsified drug delivery system (SEDDS) Int. J. Pharm. 366 2009 44 52
2. A. Ambrogi, L. Perioli, F. Marmottini, O. Accorsi, C. Pagano, M. Ricci, and C. Rossi Role of mesoporous silicates on carbamazepine dissolution rate enhancement Micropor. Mesopor. Mater. 113 2008 445 452
3. D. Bahl, and R.H. Bogner Amorphization of indomethacin by co-grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism Pharm. Res. 23 2006 2317 2325
4. D. Bahl, J. Hudak, and R.H. Bogner Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding Pharm. Dev. Technol. 13 2008 255 269
5. D. Bahl, and R.H. Bogner Amorphization alone does not account for the enhancement of solubility of drug co-ground with silicate: the case of indomethacin AAPS PharmSciTech 9 2008 146 153
6. B.J. Berne, and R. Pecora Dynamic Light Scattering: With Applications to Chemistry, Biology and Physics first ed. 1976 Wiley New York
7. S.B. Bhise, and M. Rajkumar Influence of simulated gastrointestinal fluids on polymorphic behavior of anhydrous carbamazepine form III and biopharmaceutical relevance PDA J. Pharm. Sci. Technol. 64 2010 28 36
8. J.B. Cannon Oral solid dosage forms of lipid-based drug delivery systems Am. Pharm. Rev. 8 2005 108 115
9. R.K. Chang, K.S. Raghavan, and M.A. Hussain A study on gelatin capsule brittleness: moisture transfer between the capsule shell and its content J. Pharm. Sci. 87 1998 556 558
10. P.P. Constantinides Lipid microemulsions for improving drug dissolution and oral absorption: physical and biopharmaceutical aspects Pharm. Res. 12 1995 1561 1572
11. D. Craig, S.A. Barker, D. Banning, and S. Booth An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy Int. J. Pharm. 114 1995 103 110
12. M.P. Desai, V. Labhasetwar, G.L. Amidon, and R.J. Levy Gastrointestinal uptake of biodegradable microparticles: effect of particle size Pharm. Res. 13 1996 1838 1845
13. T. Do Thi, M.V. Speybroeck, V. Barillaro, J. Martens, P. Annaert, P. Augustijns, J.V. Humbeeck, J. Vermant, and G.V. Mooter Formulate-ability of ten compounds with different physicochemical profiles in SMEDDS Eur. J. Pharm. Sci. 38 2009 479 548
14. H. El-Zein, L. Riad, and A. Abd El-Bary Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation Int. J. Pharm. 168 1998 209 220
15. A. Fehér, E. Urbán, I. Ers, P. Szabó- Révész, and E. Csányi Lyotropic liquid crystal preconcentrates for the treatment of periodontal disease Int. J. Pharm. 358 2008 23 26
16. H. Friedrich, B. Fussnegger, K. Kolter, and R. Bodmeier Dissolution rate improvement of poorly water-soluble drugs obtained by adsorbing solutions of drugs in hydrophilic solvents onto high surface area carriers Eur. J. Pharm. Biopharm. 62 2006 171 177
17. Gattefossé, S.A.; 1994. Microemulsions: Formulation Guide. Publication No. PF9225 A, Saint-Priest Cedex, France.
18. E. Gavini, A.B. Hegge, G. Rassu, V. Sanna, C. Testa, G. Pirisino, J. Karlsen, and P. Giunchedi Nasal administration of carbamazepine using chitosan microspheres: in vitro/in vivo studies Int. J. Pharm. 307 2006 9 15
19. L.S. Goodman, A.G. Gilman, J.G. Hardman, and L.E. Limbird Gilman's the Pharmacological Basis of Therapeutics tenth ed. 2001 Goodman & McGraw-Hill Book Co. New York
20. M. Gradzielski, and H. Hoffmann Rheological properties of microemulsion P. Kumar, K.L. Mittal, Handbook of Microemulsion: Science and Technology 1999 Marcel Dekker Inc. New York, Basel 357 387
21. M. Gupta, V. Adam, and R. Bogner Formation of physically stable amorphous drugs by milling with Neusilin J. Pharm. Sci. 92 2003 536 551
22. M.K. Gupta, Y.C. Tseng, D. Goldman, and R.H. Bogner Hydrogen bonding with adsorbent during storage governs drug dissolution from solid-dispersion granules Pharm. Res. 19 2002 1663 1672
23. R.N. Gursoy, and S. Benita Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs Biomed. Pharmacother. 58 2004 173 182
24. S.A. Hailu, and R.H. Bogner Complex effects of drug/silicate ratio, solid-state equivalent pH, and moisture on chemical stability of amorphous quinapril hydrochloride coground with silicates J. Pharm. Sci. 100 2012 1503 1515
25. J. Hu, K.P. Johnston, and R.O. Williams Spray freezing into liquid (SFL) particle engineering technology to enhance dissolution of poorly water soluble drugs: organic solvent versus organic/aqueous co-solvent systems Eur. J. Pharm. Sci. 20 2003 295 303
26. K. Kim, M. Frank, and N. Henderson Application of differential scanning calorimetry to the study of solid drug dispersions J. Pharm. Sci. 74 1985 283 285
27. Y. Kobayashi, S. Itai, and K. Yamamoto Physicochemical properties and bioavailability of carbamazepine polymorphs and dehydrate Int. J. Pharm. 193 2000 137 146
28. A. Kogan, A. Aserin, and N. Garti Improved solubilization of carbamazepine and structural transitions in nonionic microemulsions upon aqueous phase dilution J. Colloid Interf. Sci. 315 2007 637 647
29. Kovacs, I.; Jusztin, M.; Takacs, E.; Balazs, Z.; Kiss, I.; Varga, Z.; Jancso, S.; Heim, C.; Korcsmavos, I.K.; Erdohati, E.; Jarabin, M.; 1996. Oral pharmaceutical preparation. US Patent 5,583,105.
30. F.U. Krahn, and J.B. Mielck Relations between several polymorphic forms and the dihydrate of carbamazepine Pharm. Acta Helv. 67 1987 247 254
31. P. Li, A. Ghosha, F.R. Wagnera, S. Krillb, M.Y. Joshia, and T.M.A. Serajuddina Effect of combined use of nonionic surfactant on formation of oil-in-water microemulsions Int. J. Pharm. 288 2005 27 34
32. M. Lindenberg, S. Kopp, and J.B. Dressman Classification of orally administered drugs on the world health organization model list of essential medicines according to the biopharmaceutics classification system Eur. J. Pharm. Biopharm. 58 2004 265 278
33. M.M.J. Lowes, M.R. Caira, A.P. Lotter, and J.G. Van Der Watt Physicochemical properties and X-ray structural studies of the trigonal polymorph of carbamazepine J. Pharm. Sci. 76 1987 744 752
34. S.P. Moulik, and B.K. Paul Structure, dynamics and transport properties of microemulsions Adv. Colloid Interf. 78 1998 99 195
35. R. Nair, S. Gonen, and S.W. Hoag Influence of polyethylene glycol and povidone on the polymorphic transformation and solubility of carbamazepine Int. J. Pharm. 240 2002 11 22
36. S. Nazzal, and Y. Wang Characterization of soft gelatin capsules by thermal analysis Int. J. Pharm. 230 2001 35 45
37. Pather, S.I.; Gupte, S.V.; Khankari, K.; Hontz, J.; Robinson, J.R.; Eichman, J.D.; Kumbale, R.; 2001. Microemulsions as solid dosage forms for oral administration. US Patent 6,280,770 B1.
38. O. Planinšek, B. Kovačič, and F. Vrečer Carvedilol dissolution improvement by reparation of solid dispersions with porous silica Int. J. Pharm. 406 2011 41 48
39. C.W. Pouton, and J.H.C. Porter Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies Adv. Drug Deliv. Rev. 60 2008 625 637
40. K.K. Qian, and R.H. Bogner Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems J. Pharm. Sci. 101 2012 444 463
41. J.M. Rosen Micelle formation by surfactants J.M. Rosen, Surfactants and Interfacial Phenomena 2004 John Wilie & Sons Inc. Hoboken, NJ 105 178
42. C. Rustichelli, G. Gamberini, V. Ferioli, M.C. Gamberini, R. Ficarra, and S. Tommasini Solid-state study of polymorphic drugs: carbamazepine J. Pharm. Biomed. 23 2000 42 54
43. M.V. Speybroeck, V. Barillaro, T. Do Thi, R. Mellaerts, J. Martens, J.V. Humbeeck, J. Vermant, P. Annaert, G. Van den Mooter, and P. Augustijns Ordered mesoporous silica material SBA-15: a broad-spectrum formulation platform for poorly soluble drugs J. Pharm. Sci. 98 2009 2648 2658
44. J. Vanderscher, and A. Meinzer Rationale for the development of Sandimmune Neoral Transplant. Proc. 26 1994 2925 2927
45. N. Zerrouk, S. Toscani, J.M. Gines-Dorado, C. Chemtob, R. Ceólin, and J. Dugué Interactions between carbamazepine and polyethylene glycol (PEG) 6000: characterisations of the physical, solid dispersed and eutectic mixtures Eur. J. Pharm. Sci. 12 2001 395 404
46. Q. Zhang, X. Jiang, W. Jiang, W. Lu, L. Su, and Z. Shi Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain Int. J. Pharm. 275 2004 85 96